User profiles for N. COOPER

Nicola Cooper

- Verified email at le.ac.uk - Cited by 17685

Nichola Cooper

- Verified email at imperial.ac.uk - Cited by 17113

Nigel Cooper

- Verified email at cam.ac.uk - Cited by 11425

Inflammation and Alzheimer's disease

…, S Barnum, B Bradt, J Bauer, GM Cole, NR Cooper… - Neurobiology of …, 2000 - Elsevier
Inflammation clearly occurs in pathologically vulnerable regions of the Alzheimer’s disease (AD)
brain, and it does so with the full complexity of local peripheral inflammatory responses. …

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

CL Gillies, KR Abrams, PC Lambert, NJ Cooper… - Bmj, 2007 - bmj.com
Objective To quantify the effectiveness of pharmacological and lifestyle interventions to
prevent or delay type 2 diabetes in people with impaired glucose tolerance. Data sources …

American Society of Hematology 2019 guidelines for immune thrombocytopenia

…, DM Arnold, G Buchanan, DB Cines, N Cooper… - Blood …, 2019 - ashpublications.org
Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

…, DJ Mcshane, JF Fries, NS Cooper… - … : Official Journal of …, 1988 - Wiley Online Library
The revised criteria for the classification of rheumatoid arthritis (RA) were formulated from a
computerized analysis of 262 contemporary, consecutively studied patients with RA and 262 …

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working …

…, DB Cines, BH Chong, N Cooper… - Blood, The Journal …, 2009 - ashpublications.org
Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely
dependent on clinical expertise and observations more than on evidence derived from clinical …

Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a …

…, CL Hibbert, A Truesdale, F Clemens, N Cooper… - The Lancet, 2009 - thelancet.com
… 766 patients were screened; 180 were enrolled and randomly allocated to consideration
for treatment by ECMO (n=90 patients) or to receive conventional management (n=90). 68 (75%…

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

…, R Zarychanski, JK Baillie, R Beasley, N Cooper… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

Cryoglobulinemia—a clinical and laboratory study: II. Cryoglobulins with rheumatoid factor activity

…, EC Franklin, K Elias, RT McCluskey, N Cooper - The American journal of …, 1966 - Elsevier
Detailed clinical and laboratory studies of twelve subjects with cryoglobulins associated with
rheumatoid factor activity are presented. These patients constituted 41 per cent of twenty-…

[HTML][HTML] Measuring the Chern number of Hofstadter bands with ultracold bosonic atoms

…, S Nascimbene, NR Cooper, I Bloch, N Goldman - Nature Physics, 2015 - nature.com
… Here annihilates (creates) a particle on site (m, n), where the position in the lattice is defined
as , with m, n integers and the unit vectors. In the limit Δ ≫ κ, the effective coupling strengths …

[HTML][HTML] Tocilizumab in hospitalized patients with severe Covid-19 pneumonia

…, S Bhagani, D Skiest, MS Aziz, N Cooper… - … England Journal of …, 2021 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation
and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a …